Next Article in Journal
Molecular Targeting of Acid Ceramidase in Glioblastoma: A Review of Its Role, Potential Treatment, and Challenges
Next Article in Special Issue
Inline Determination of Residence Time Distribution in Hot-Melt-Extrusion
Previous Article in Journal
Prediction of Renal Acid Load in Adult Patients on Parenteral Nutrition
Article Menu
Issue 2 (June) cover image

Export Article

Open AccessArticle
Pharmaceutics 2018, 10(2), 44; https://doi.org/10.3390/pharmaceutics10020044

Material Considerations for Fused-Filament Fabrication of Solid Dosage Forms

1
Materials Research Institute, Athlone Institute of Technology, Dublin Road, N37 HD68 Athlone, Ireland
2
School of Pharmacy, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK
*
Author to whom correspondence should be addressed.
Received: 11 March 2018 / Revised: 27 March 2018 / Accepted: 28 March 2018 / Published: 2 April 2018
(This article belongs to the Special Issue Pharmaceutical Applications of Hot-melt Extrusion)
View Full-Text   |   Download PDF [60906 KB, uploaded 3 May 2018]   |  

Abstract

Material choice is a fundamental consideration when it comes to designing a solid dosage form. The matrix material will ultimately determine the rate of drug release since the physical properties (solubility, viscosity, and more) of the material control both fluid ingress and disintegration of the dosage form. The bulk properties (powder flow, concentration, and more) of the material should also be considered since these properties will influence the ability of the material to be successfully manufactured. Furthermore, there is a limited number of approved materials for the production of solid dosage forms. The present study details the complications that can arise when adopting pharmaceutical grade polymers for fused-filament fabrication in the production of oral tablets. The paper also presents ways to overcome each issue. Fused-filament fabrication is a hot-melt extrusion-based 3D printing process. The paper describes the problems encountered in fused-filament fabrication with Kollidon® VA64, which is a material that has previously been utilized in direct compression and hot-melt extrusion processes. Formulation and melt-blending strategies were employed to increase the printability of the material. The paper defines for the first time the essential parameter profile required for successful 3D printing and lists several pre-screening tools that should be employed to guide future material formulation for the fused-filament fabrication of solid dosage forms. View Full-Text
Keywords: 3D printing; fused-filament fabrication; additive manufacturing; hot-melt extrusion; formulation; melt-blending; solid dosage forms; tablets 3D printing; fused-filament fabrication; additive manufacturing; hot-melt extrusion; formulation; melt-blending; solid dosage forms; tablets
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Fuenmayor, E.; Forde, M.; Healy, A.V.; Devine, D.M.; Lyons, J.G.; McConville, C.; Major, I. Material Considerations for Fused-Filament Fabrication of Solid Dosage Forms. Pharmaceutics 2018, 10, 44.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top